Marqeta, Inc. MQ
New risk paragraphs, branching off last year
Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Feb 26, 2025. A box jumps to the paragraph as filed, below.
Paragraphs with nothing like them in last year's 10-K
3 paragraphs in Risk Factors of the 10-K filed Feb 24, 2026 with nothing like them in the 10-K filed Feb 26, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
Certain of our subsidiaries (for example, TransactPay) have obligations related to managing restricted cash funded by customers for card and e-money programs, which must be segregated and safeguarded pursuant to applicable regulatory requirements. While these funds are client-deposited and offset by corresponding liabilities and thus does not directly restrict our own cash, rapid growth in customer balances, regulatory changes requiring higher reserves, or operational shortfalls could necessitate additional capital to ensure compliance, cover potential gaps, or enhance safeguarding mechanisms (e.g., insurance or trusts). This could indirectly strain our funding needs if mismatches arise. This function creates a risk of financial loss, operational disruptions, and/or reputational harm arising from, among other things, fraud by employees or third parties, execution of unauthorized transactions, cybersecurity events or security breaches, any failure to maintain proper segregation, errors relating to transaction processing, or any failure to comply with safeguarding rules.
A portion of our net revenue is derived from Interchange Fees and the amount of Interchange Fees we earn is highly dependent on the interchange rates that the Card Networks set and adjust. Interchange Fees and assessments are subject to change from time to time by the Card Networks and due to government regulation. Most recently, effective October 2025, Visa implemented a new interchange program, Commercial Enhanced Data Program (CEDP) which reduces some interchange rates as a merchant incentive to provide robust transaction details (Level 3 data) on Commercial and Business Card programs which results in lower interchange revenue to Marqeta and our Commercial and Business Card customers. The CEDP program will also sunset Level 2 interchange programs effective April 2026, and will cause transactions to either clear at a higher or the new lower CEDP interchange rate.
Our Board of Directors has periodically authorized share repurchase programs for repurchases of shares of our Class A common stock, including most recently the authorization on December 4th, 2025, for the repurchase of up to an aggregate of $100 million of our Class A common stock (the “December 2025 Share Repurchase Program”). The actual timing, manner, number, and value of shares repurchased under the December 2025 Share Repurchase Program will depend on a number of factors, including the availability
Paragraphs in the 10-Q filed Nov 3, 2026 that were not in the one before
New in the latest 10-Q
30 paragraphs in the 10-Q filed Nov 3, 2026 with nothing like them in the 10-Q filed Aug 4, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
10-Q
• changes to our expectations regarding our income tax liabilities, including any changes regarding foreign taxes, realizability of deferred tax assets, valuation allowances, and the adequacy of our reserves;
Read in the 10-Q
Financial statements and notes
In May 2025, the FASB issued Accounting Standards Update No. 2025-04, “Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer” (“ASU 2025-04”). ASU 2025-04 clarifies that share-based consideration granted to a customer is measured and classified in accordance with ASC Topic 718, and that the variable consideration constraint of ASC Topic 606 does not apply to such awards. The update also explicitly incorporates conditions based on customer purchases or contract execution into the definition of "performance conditions," requiring the Company to estimate vesting probability upfront under ASC Topic 718. Finally, the standard eliminates the accounting policy election to record forfeitures as they occur for customer share-based awards, requiring that forfeitures be estimated.
Read in the 10-Q
The Company early adopted ASU 2025-04 on a modified retrospective basis as of January 1, 2026. As of the adoption date, all previously issued customer common stock warrants had fully vested and none remained outstanding. Remaining capitalized warrant assets from previous vestings continue to be amortized as a reduction of net revenue over the remaining contract term. Because the previously issued warrants had already fully vested, the adoption of this standard did not have any impact on the Company’s condensed consolidated financial statements as of the adoption date. Warrants issued during the three and nine months ended September 30, 2026 were assessed and accounted for in accordance with the guidance in ASU 2025-04.
Read in the 10-Q
The increase in deferred tax assets, net as of September 30, 2026 primarily reflects the recognition of deferred tax assets related to U.S. net operating losses, federal tax credits carryforwards, and capitalized research and development expenditures following the release of a significant portion of the related valuation allowances during the three and nine months ended September 30, 2026. See Note 13 for additional information.
Read in the 10-Q
Company’s failure to perform under its program agreement. No significant claims have been incurred during the three and nine months ended September 30, 2026 and 2025.
Read in the 10-Q
Show the other 25
On September 2, 2026, in connection with the renewal of a commercial agreement, the Company issued a warrant to a certain customer to purchase up to 550,000 shares of the Company's Class A common stock (the “2026 Warrant”). Upon exercise of the earned portion of the 2026 Warrant, the customer will be entitled to purchase shares of the Company’s Class A common stock at a price of $ 0.01 per share. A warrant was previously issued to the same customer under the original agreement executed in September 2020. No warrant previously issued to the customer remained outstanding prior to the issuance of the 2026 Warrant. The 2026 Warrant is classified as an equity instrument and treated as consideration payable to a customer. The Company determined the grant-date fair value of the 2026 Warrant to be $ 16.81 per share underlying the warrant based on the Black-Scholes valuation model.
Read in the 10-Q
Upon execution of the agreement in the third quarter of 2026, the portion of the 2026 Warrant representing the right to purchase 25,000 shares was earned. The $ 0.4 million total grant-date fair value of this earned portion of the 2026 Warrant was capitalized, with an offsetting credit to additional paid-in capital, and is being recognized on a straight-line basis as a reduction of net revenue over the five-year contract term. The remaining portion of the 2026 Warrant, representing the right to purchase up to 525,000 shares, could be earned and become exercisable in tranches, subject to the terms of the 2026 Warrant, upon the achievement of specific milestones related to transaction volume over the five-year term. The grant-date fair value of any portion of the 2026 Warrant that is earned is recognized as a reduction of net revenue in the period the related volume tier is achieved, with a corresponding credit to additional paid-in capital.
Read in the 10-Q
Portions of the 2026 Warrant that are earned between July 1 of any year and June 30 of the following year will become vested and exercisable at any time on or after August 1 of the following year. For example, portions that are earned between July 1, 2026 and June 30, 2027 vest and become exercisable on August 1, 2027.
Read in the 10-Q
As of September 30, 2026, the portion of the 2026 Warrant representing the right to purchase 36,250 shares has been earned, but is not exercisable until August 1, 2027. The Company recorded a $ 0.2 million reduction in net revenue related to the earned portion of the 2026 Warrant for both the three and nine months ended September 30, 2026.
Read in the 10-Q
The Company has revised its previously reported remaining authorization as of the date of filing of its Quarterly Report on Form 10-Q filed with the SEC on August 4, 2026, as well as the Current Report on Form 8-K filed with the SEC on August 4, 2026, which was understated by $ 1.3 million due to clerical errors identified by the Company and a vendor. After giving effect to the correction, the available amount remaining under authorization as of June 30, 2026 was $ 2.1 million. There was no material change to stockholders' equity as a result of the revision. The Company has assessed the materiality of the errors and determined they were not material to the condensed consolidated financial statements as of and for the three and six months ended June 30, 2026.
Read in the 10-Q
The benefit for income taxes for the three and nine months ended September 30, 2026 was mainly attributable to the release of a significant portion of the valuation allowance on the Company’s U.S. federal and certain states’ deferred tax assets, which resulted in a $ 106.6 million income tax benefit, partially offset by income tax expense from current period activity.
Read in the 10-Q
The provision for income taxes recorded in the three and nine months ended September 30, 2025 consists of state and foreign income taxes in foreign jurisdictions in which the Company conducts business.
Read in the 10-Q
The Company regularly assesses the need for a valuation allowance on its deferred tax assets. In performing that assessment, the Company considers both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of all available evidence, whether it is more-likely-than-not that some or all of the deferred tax assets will be realized. The determination of the realizability of deferred tax assets involves significant judgment and relies on management's estimates of future taxable income.
Read in the 10-Q
The Company had cumulative U.S. pre-tax book income, adjusted for permanent book-tax differences, over the twelve-quarter period ended September 30, 2026 and expects to continue to sustain this profitability position for the foreseeable future. This cumulative profitability represents objective and verifiable positive evidence that carries significant weight. After evaluating all available positive and negative evidence, including this cumulative profitability and anticipated future earnings, the Company concluded that it is more-likely-than-not that the U.S. federal and certain states’ deferred tax assets are realizable. As a result of this change in judgment, the Company released a significant portion of the valuation allowance previously recorded against its U.S. deferred tax assets during the three and nine months ended September 30, 2026. The majority of the released valuation allowance related to U.S. federal and state net operating losses, federal tax credit carryforwards and capitalized research and development (“R&D”) expenditures. Because the change in estimate occurred during an interim period, the portion of the valuation allowance release attributable to current year income was included in the estimated annual effective tax rate, while the release supported by projections of future taxable income is recorded as a discrete benefit. The Company released $ 106.6 million of valuation allowance as a discrete tax benefit during the three and nine months ended September 30, 2026.
Read in the 10-Q
The Company’s judgment regarding the need for a valuation allowance may reasonably change in future reporting periods due to many factors, including changes in expectations of future profitability in the U.S. and changes in tax laws or regulations. The Company will continue to maintain a valuation allowance against deferred tax assets where the Company believes that it is more-likely-than-not that some or all the deferred tax assets will not be realized. The remaining valuation allowance as of September 30, 2026 was $ 11.0 million, maintained against deferred tax assets related to California R&D credits.
Read in the 10-Q
The Company is subject to income tax examination in the United States and foreign jurisdictions. Because the Company has net operating loss and R&D tax credits carryforwards for U.S. federal and state jurisdictions, the statute of limitations is open for all tax years. The Company believes it has provided adequate reserves for uncertain tax positions in all open tax years.
Read in the 10-Q
Income tax expense generally consists of U.S. federal and state income taxes, and income taxes related to certain foreign jurisdictions. We regularly assess the need for a valuation allowance on our deferred tax assets. We had cumulative U.S. pre-tax book income, adjusted for permanent book-tax differences, over the twelve-quarter period ended September 30, 2026, and expect to continue to sustain this profitability position for the foreseeable future. This cumulative profitability represents objective and verifiable positive evidence that carries significant weight that supported the realization of the U.S. federal and certain states’ deferred tax assets as of September 30, 2026. After evaluating all available positive and negative evidence, including this cumulative profitability and anticipated future earnings, we concluded that it is more-likely-than-not that the U.S. federal and certain states’ deferred tax assets are realizable as of September 30, 2026. As a result, we released a significant portion of our valuation allowance on the deferred tax assets in the U.S., resulting in the recognition of deferred tax assets and income tax benefit of $106.6 million during the three and nine months ended September 30, 2026, which was partially offset by income tax expense from current period activity. The release resulted in a discrete, non-cash increase in GAAP income tax benefit, and a corresponding increase in GAAP net income and GAAP earnings per share for the three and nine months ended September 30, 2026.
Read in the 10-Q
We expect cash taxes to remain below book income tax expense as we utilize net operating loss and tax credit carryforwards, subject to applicable limitations. We will continue to assess all available evidence each reporting period. Our judgment regarding the need for a valuation allowance may change due to the level of tax profitability we achieve, changes in enacted tax law, or other factors.
Read in the 10-Q
Income tax benefit was $104.4 million for the three months ended September 30, 2026, compared to an income tax expense of $0.5 million for the three months ended September 30, 2025. The year-over-year change was mainly attributable to a $106.6 million benefit from the release of a significant portion of the valuation allowance on our U.S. federal and certain states’ deferred tax assets during the three months ended September 30, 2026, partially offset by income tax expense from current period activity. The release of the valuation allowance was recorded as a discrete tax benefit and resulted in the recognition of certain deferred tax assets and a corresponding increase to net income for the three months ended September 30, 2026.
Read in the 10-Q
Income tax benefit was $103.7 million for the nine months ended September 30, 2026, compared to an income tax expense of $0.9 million for the nine months ended September 30, 2025. The year-over-year change was mainly attributable to a $106.6 million benefit from the release of a significant portion of the valuation allowance on our U.S. federal and certain states’ deferred tax assets during the nine months ended September 30, 2026, partially offset by income tax expense from current period activity. The release of the valuation allowance was recorded as a discrete tax benefit and resulted in the recognition of certain deferred tax assets and a corresponding increase to net income for the nine months ended September 30, 2026.
Read in the 10-Q
(3) Non-recurring litigation expense includes a legal contingency expense related to the Securities Actions recorded during the three and nine months ended September 30, 2025.
Read in the 10-Q
(4) The income tax benefit recorded during the three and nine months ended September 30, 2026 was primarily due to the release of valuation allowances related to U.S. federal and certain states’ deferred tax assets, partially offset by the income tax expense from current period activity.
Read in the 10-Q
The release of the valuation allowance against our U.S. federal and certain states’ deferred tax assets during the three and nine months ended September 30, 2026 was a non-cash item and did not affect our cash, cash equivalents, or short-term investments. Cash taxes paid may increase over time as net operating loss and tax credit carryforwards are utilized or become limited.
Read in the 10-Q
We evaluate the realizability of our deferred tax assets based on positive and negative evidence, including historical results, projections of future taxable income, and other factors. This assessment requires significant management judgment and can change as new information becomes available or actual results differ from projections. Adjustments to the valuation allowance are recorded through the income tax provision and can materially affect our results of operations.
Read in the 10-Q
We had cumulative U.S. pre-tax book income, adjusted for permanent book-tax differences, over the twelve-quarter period ended September 30, 2026, and expect to continue to sustain this profitability for the foreseeable future. This cumulative profitability represents objective and verifiable positive evidence that carries significant weight. After evaluating all available positive and negative evidence, including anticipated future earnings, we concluded that it is more-likely-than-not that the U.S. federal and certain states’ deferred tax assets are realizable. Accordingly, we released $106.6 million of valuation allowance during the three and nine-months ended September 30, 2026, primarily related to U.S. federal and state operating losses, federal tax credit carryforwards, and capitalized R&D expenditures. We continue to maintain a valuation allowance of $11.0 million against our California R&D credits, as we believe it is more-likely-than-not that these deferred tax assets will not be realizable. For additional information, see Note 13 to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report.
Read in the 10-Q
Our assessment of the realizability of deferred tax assets is sensitive to changes in projected taxable income. A sustained decline in profitability or a significant reduction in projected future taxable income could result in the need to re-establish a valuation allowance against some or all of the deferred tax assets for which the allowance was released. We will continue to evaluate the realizability of our deferred tax assets based on all available evidence each reporting period.
Read in the 10-Q
Share sales and buybacks
On September 2, 2026, we granted a certain customer a warrant to purchase up to 550,000 shares of Class A common stock at an exercise price of $0.01 per share, pursuant to a renewal of the commercial agreement with the customer (the “2026 Warrant”). No portion of the 2026 Warrant is currently exercisable. As of September 30, 2026, the portion of the 2026 Warrant representing the right to purchase 36,250 shares had been earned, including the portion representing 25,000 shares that was earned upon execution of the agreement. The remaining portion of the 2026 Warrant, representing the right to purchase up to 513,750 shares, could be earned and become exercisable in tranches, subject to the terms of the 2026 Warrant, upon the achievement of specific milestones relating to transaction volume. Portions of the 2026 Warrant that are earned between July 1 of any year and June 30 of the following year will become vested and exercisable at any time on or after August 1 of the following year. For example, portions that are earned between July 1, 2026 and June 30, 2027 vest and become exercisable on August 1, 2027. We did not receive cash consideration for the 2026 Warrant.
Read in the 10-Q
We believe this transaction was exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act as a transaction by an issuer not involving any public offering. The customer represented its intention to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the warrant. The customer had adequate access, through its relationship with us, to information about Marqeta.
Read in the 10-Q
We have revised our previously reported remaining authorization under the December 2025 Share Repurchase Program as of the date of filing of our Quarterly Report on Form 10-Q filed with the SEC on August 4, 2026, as well as the Current Report on Form 8-K filed with the SEC on August 4, 2026, which was understated by $1.3 million due to clerical errors identified by us and a vendor. After giving effect to the correction, the available amount remaining under authorization as of June 30, 2026 was $2.1 million.
Read in the 10-Q
Item 6
4.1*† Warrant to Purchase Common Stock issued to Uber Technologies, Inc. by the Registrant, dated September 2, 2026.
Read in the 10-Q
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Nov 3, 2026 against Item 1A of the 10-K filed Feb 24, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted).
Text on the page, not a score; each links to the filing at sec.gov.
What the 10-Q itself says about its risk factors:but not limited to those described in Part I, Item 1A of our 2025 Annual Report and in Part II, Item 1A of our Quarterly Report on Form 10-Q filed with the SEC on May 5, 2026 under the heading "Risk Factors," which are incorporated herein by reference, any one or more of which could, directly or indirectly, materially and adversely affect our business, financial condition, results of operations, cash flows, future prospects, and the trading price of our Class A common stock, or cause them to vary materially from past or anticipated future results.
Read in the 10-Q
What the 10-Q itself says about its risk factors:There have been no material changes from the risk factors previously disclosed under “Part I, Item 1A. Risk Factors” in our 2025 Annual Report and “Part II, Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q, each as discussed in the preceding paragraph.
Read in the 10-Q
Phrases used for the first time
Two-word phrases in Risk Factors of the 10-K filed Feb 24, 2026 that are in none of the 1 earlier 10-Ks stored, back to Feb 26, 2025
Where each one is used
- december share: Our Board of Directors has periodically authorized share repurchase programs for repurchases of shares of our Class A common stock, including most recently the authorization on December 4th, 2025, for the repurchase of up to an aggregate of $100 million of our Class A common stock (the “December 2025 Share...
- marqeta hub: Net revenue growth attributed to our new technologies, such as portfolio migration, UX Toolkit, and the development of Marqeta Hub is dependent on increasing the number of existing customers or new customers who use our platform and these capabilities. Failure to scale these technologies, a competitive market, or...
- emi license: As our business and platform continue to develop and expand, we continue to become subject to additional laws, rules, regulations, and industry standards, including possible additional examination and supervision, in the United States and internationally. For example, in Canada, the Retail Payment Activities Act...
- fee regulations: A portion of our net revenue is derived from Interchange Fees and changes in Interchange Fees or Interchange Fee regulations, or in interpretation of existing regulations, could adversely affect our business, results of operations, and financial condition.
- currently qualify: Interchange Fees have historically been, and continue to be, the subject of intense legal and regulatory scrutiny and competitive pressures in the payments industry in the United States and internationally. For example, in the UK, the Interchange Fee Regulations may restrict or place caps on the interchange fees...
- pillar two: Additionally, successful assertion by one or more states, or foreign jurisdictions, requiring us to collect sales, value added, or similar indirect taxes where we presently do not do so, or to collect more of such indirect taxes in a jurisdiction in which we currently do collect some indirect taxes, could result in...
Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.
What was taken out
1 paragraph of last year's Risk Factors with nothing like them now. The longest are quoted.
Sources
Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.
Also
10-K change: what was reworded or cut, section by section.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MQ/export.csv") into a cell.